+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ANTHEM

Anthem Biosciences Share Price

₹940.90 -1.4 (-0.15%)
New 52W High in past week

11 Sep, 2026 3:51 PM (IST)

Anthem Biosciences live price: ₹940.90. It opened at ₹938 vs previous close ₹942; intraday high/low: ₹952/₹933. The 50 & 200 DMA stand at ₹864.40/₹779.10.

Anthem Biosciences Performance

  • Today's Low
  • ₹933
  • Today's High
  • ₹952
  • 52 Week Low
  • ₹579
  • 52 Week High
  • ₹978
  • Open Price₹938
  • Previous Close₹942
  • Volume890,004
  • 50 DMA₹864.40
  • 100 DMA₹818.10
  • 200 DMA₹779.10

Anthem Biosciences Chart

Investment Returns

  • Over 1 Month + 5.52%
  • Over 3 Month + 20.62%
  • Over 6 Month + 45.03%
  • Over 1 Year + 14.62%

Smart Investing Starts Here Start SIP with Anthem Biosciences for Steady Growth!

Invest Now

Anthem Biosciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 92
  • PEG Ratio
  • 6.5
  • Market Cap Cr
  • 52,991
  • P/B Ratio
  • 16.8
  • Average True Range
  • 29.1
  • EPS
  • 10.2
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 28.1
  • RSI
  • 63
  • MFI
  • 62.31

Latest Stock News Updates

Anthem Biosciences Ltd - 544449 - Settlement Of Upside Sharing Arrangement

Intimation of the settlement of Upside Sharing Arrangement

Jefferies initiates coverage on Anthem Biosciences with a Rs 1,050 target

Jefferies has initiated coverage on Anthem Biosciences with a Buy rating and Rs 1,050 target, implying around 20% upside. The brokerage is bullish on the company's integrated CRDMO model, strong return ratios and growth prospects, forecasting 18% revenue CAGR through FY29. Key triggers include new commercial molecules and biosimilar launches, while customer concentration and high capex remain key risks.

Anthem Biosciences Ltd - 544449 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Earnings Conference Call held on July 22, 2026.

Anthem Biosciences Financials

Anthem Biosciences Technicals

EMA & SMA

Current Price
₹940.90
-1.4 (-0.15%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹913.50
  • 50 Day
  • ₹864.40
  • 100 Day
  • ₹818.10
  • 200 Day
  • ₹779.10

Resistance and Support

941.87 Pivot Speed
  • R3 970.30
  • R2 961.20
  • R1 951.00
  • S1 931.70
  • S2 922.60
  • S3 912.40

Anthem Biosciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-21 Quarterly Results
2026-05-19 Audited Results & Final Dividend
2026-02-05 Quarterly Results
2025-11-08 Quarterly Results
2025-08-13 Quarterly Results
Date Purpose Remarks
2026-06-26 FINAL Rs.2.00 per share(100%)Final Dividend
View Anthem Biosciences Dividend History Arrow

Anthem Biosciences Shareholding Pattern

71.42%
12.52%
11.15%
2.57%
2.33%

About Anthem Biosciences

Anthem Biosciences operates in biotechnology sector and its business activities includes, discover, develop, manufacture, and commercialize biopharmaceutical products that address significant unmet needs and provide biological solutions to improve industrial performance in all areas. View More
  • NSE Symbol
  • ANTHEM
  • BSE Symbol
  • 544449
  • Chairman.,Executive Director,Managing Director,Chief Executive Officer
  • Ajay Bhardwaj
  • ISIN
  • INE0CZ201020

Similar Stocks to Anthem Biosciences

Anthem Biosciences FAQs

Anthem Biosciences share price is ₹940 As on 12 September, 2026 | 15:39

The Market Cap of Anthem Biosciences is ₹52991 Cr As on 12 September, 2026 | 15:39

The P/E ratio of Anthem Biosciences is 92 As on 12 September, 2026 | 15:39

The PB ratio of Anthem Biosciences is 16.8 As on 12 September, 2026 | 15:39

The 52 week High & Low of Anthem Biosciences is ₹977.6/₹579.2 respectively As on 12 September, 2026 | 15:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23